Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Just saw that Globus Medical's got a new CEO now. Keith Pfeil moved up from COO to take over the top spot after Daniel Scavilla stepped down. He's been with them since 2019, so at least there's some continuity there. Kyle Kline got bumped up to CFO too.
What caught my attention though—Q2 numbers came in at $745.3M, up 18.4% year-over-year. That's solid growth, but the organic stuff? Only 3.3% increase when you strip out acquisitions. So a lot of that growth is coming from their Nevro deal. Their US Spine business hit its highest quarterly revenue since the NuVasive merger though, which is interesting.
They're sticking with their 2025 guidance of $2.8-2.9B revenue. Keith Pfeil seems confident about the trajectory, especially with the Enabling Technologies pipeline they're working on. Curious to see if they can maintain this momentum without leaning too hard on M&A.